How ADHD Meds Affect the Brain
Why It Matters
Accurate knowledge of ADHD’s neurobiology and stimulant action guides safer prescribing, improves symptom control, and reduces the risk of diversion or ineffective treatment.
Key Takeaways
- •ADHD brains show reduced prefrontal cortex volume and activity
- •Cerebellum, hippocampus, basal ganglia, amygdala also structurally abnormal
- •Neurotransmitter deficits in dopamine and norepinephrine impair focus
- •Stimulant meds increase neurotransmitter levels via release or reuptake blockade
- •Adderall IR lasts 5‑8 hours; XR extends to 10‑12 hours
Summary
The video explains how ADHD alters brain structure and chemistry, focusing on the pre‑frontal cortex, cerebellum, hippocampus, basal ganglia and amygdala, and then examines how prescription stimulants modify those neurobiological deficits.
Researchers note that ADHD brains have smaller pre‑frontal volume and reduced activity, alongside atypical sizes in regions governing motor coordination, memory, reward and emotion. Neurotransmitter levels of dopamine and norepinephrine are also lower, which underlies the characteristic inattention, poor motivation and impulsivity.
Stimulant medications such as Adderall (amphetamine) and methylphenidate work by boosting these neurotransmitters—Adderall forces dopamine release from nerve terminals, while methylphenidate blocks re‑uptake, keeping dopamine and norepinephrine in the synapse longer. The video cites that Adderall IR lasts five to eight hours, whereas the XR formulation extends effects to ten‑12 hours.
Understanding these mechanisms helps clinicians match dosage form to patient needs, informs patients about expected duration and potential for misuse, and underscores why FDA‑approved stimulants remain the first‑line therapy despite abuse concerns.
Comments
Want to join the conversation?
Loading comments...